Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05803603 · ClinicalTrials.gov registry record · NA
Social Work Assistance and Stipends for Housing (SASH)
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT05803603: Completed NA study, sponsored by University of Maryland, Baltimore.
NCT05803603 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05803603, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
SASH is a clinical trial feasibility study that will provide an intervention to improve Opioid Use Disorder (OUD), Quality of Life (QOL), and housing outcomes for homeless patients receiving Medication for Opiate Use Disorder (MOUD). The main questions of the study are does a $500 housing stipend for individuals on MOUD increase treatment retention, improved quality of life and prevent homelessness.
Primary Outcome
Percentage of Missed Methadone Doses, Range 0 - 100%, Lower percentages mean better outcome.
Interventions
- BEHAVIORAL Stipend and Social Work Supports
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2024-01-01 |
| Phase | NA |
What the finished NCT05803603 record still lists
NCT05803603 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Stipend and Social Work Supports is the first listed.
NCT05803603 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05803603 about?
NCT05803603 is a clinical study titled "Social Work Assistance and Stipends for Housing (SASH)". SASH is a clinical trial feasibility study that will provide an intervention to improve Opioid Use Disorder (OUD), Quality of Life (QOL), and housing outcomes for homeless patients receiving Medication for Opiate Use Disorder (MOUD). The main questions of the study are does a $500 housing stipend fo...
What is the current status of trial NCT05803603?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2022-12-01. Estimated completion is 2024-01-01.
What interventions are being tested in trial NCT05803603?
The interventions under investigation include: Stipend and Social Work Supports (BEHAVIORAL).
Who is sponsoring clinical trial NCT05803603?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05803603's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI